Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
Class II Recall
The Harvard Drug Group
Product
Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4
Reason
Packaging defect: observed packaging defect, blister packaging inadequately sealed.
Classification
Class II
Status
Terminated
Lot
Lot: M04145 Exp. 01/2024
Date
2023-03-08
Disclaimer:
This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.